Long-term pain -or pain that lasts for months or years-is one of the most common health problems in the United States. Clinicians often prescribe opioids which can help ease pain in the short term, but evidence does not support their effectiveness over the long term. For some people, long-term opioid use can lead to addiction and overdose. People need effective options and support to help maintain or improve their function and quality of life. This study compared two programs for helping people living with long-term pain who have been prescribed opioids for 3 or more months. This study was done at primary care and pain care clinics at 3 health systems in the Southeastern United States. The study team assigned people by chance to one of two study programs: (1) individual motivational interviewing plus group-based cognitive behavioral therapy (MI+CBT) or (2) patient-clinician shared decision making. In the MI+CBT program, the patient learned strategies to better cope with chronic pain. In the SDM program, the patient and clinician worked together through enhanced communication to make decisions that aligned with values and preferences of the patient. The study team compared the two programs by looking at changes in opioid dosage, physical functioning, and pain interference over time. They collected information about prescribed opioid dosage from electronic health records and patients completed surveys at the start of the study and 6 and 12 months later. The study team worked with an advisory group that included patients, advocates, clinicians, and pain experts. The advisory group met with the study team two to three times per year to provide input on the study.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 12
Timeframe: Month 12 (PRIMARY TIMEPOINT)
Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 3
Timeframe: Month 3
Change From Baseline in Average Daily Opioid Dose in in Morphine Milligram Equivalents (MME) at Month 6
Timeframe: Month 6
Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 9
Timeframe: Month 9
Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 15
Timeframe: Month 15
Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 18
Timeframe: Month 18
Change From Baseline of at Least 10 Morphine Milligram Equivalents (MME) at Month 12
Timeframe: Month 12
Change From Baseline of at Least 10 Morphine Milligram Equivalents (MME) at Month 3
Timeframe: Month 3
Change From Baseline of at Least 10 Morphine Milligram Equivalents (MME) at Month 6
Timeframe: Month 6
Change From Baseline of at Least 10 Morphine Milligram Equivalents (MME) at Month 9
Timeframe: Month 9
Change From Baseline of at Least 10 Morphine Milligram Equivalents (MME) at Month 15
Timeframe: Month 15
Change From Baseline of at Least 10 Morphine Milligram Equivalents (MME) at Month 18
Timeframe: Month 18